Punjab, April 27 -- PARIS, April 27, 2026 /PRNewswire/ -A new study has established that treatment with essential phospholipids (Essentiale) resulted in a 2.5 times greater reduction in liver fat, significant improvement in fatigue and improvement of glycaemic control in individuals with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) - also known as 'Fatty Liver Disease' - than diet and exercise alone. The results were found by the EXCEL clinical trial from Essentiale (an Opella brand) - a multi-centre, randomized, double-blind, placebo-controlled study and the first of its kind to test essential phospholipids (EPLs). The study examined MASLD patients with comorbidities such as type 2 diabetes, hyperlipidaemia, or obesity....